Novartis, Google to Develop Contact Lenses to Monitor Blood Sugar

Finger-prick glucose tests could soon be a pain of the past. The two mega companies have joined forces to make biosensor-packed smart lenses a reality for diabetes patients.

learn more about Kim Lachance Shandrow

By Kim Lachance Shandrow

Opinions expressed by Entrepreneur contributors are their own.

Novartis officially has eyes for Google's smart contact lenses.

The Swiss pharmaceutical giant announced today that its Alcon eye care division is joining forces with Google X, the search juggernaut's top secret research lab, to develop contact lenses that would monitor diabetic patients' glucose levels and autofocus the eyes of users who can't read without glasses.

Neither mega company is sharing the financial particulars of the deal, which Novartis noted is still subject to antitrust approvals.

Related: Google's Next Crazy Project: Smart Contact Lenses

Google's prototype smart contact lenses raised eyebrows earlier last January when the Mountain View, Calif., tech mammoth first opened up about the cutting-edge biometrics project.

Under the new agreement, Novartis will expand on Google's original prototype vision for the lenses, which are embedded with glitter-sized microchips and wireless glucose sensors, and an antenna finer than a strand of human hair.

Google designed its prototype to track diabetes sufferers' blood glucose levels found in their tears using the super-tiny electronic components sandwiched between two layers of soft contact lens material. The data the lenses continuously collect could be transmitted in real-time to mobile devices, allowing them to be quickly and easily tracked by doctors and patients.

Related: Google Wants to Patent Contact Lenses That Can Snap Photos

Some 382 million people across the world have diabetes, according to the International Diabetes Federation. For many of them, these smart lenses could provide a pain-free alternative to pricking their fingers, sometimes up to a dozen or so times per day, to gauge their blood sugar levels.

Novartis is sticking with Google's original glucose monitoring vision for the smart lenses, but said it's also interested in exploring potential applications that could help people diagnosed with presbyopia, an aging-related condition involving the inability to focus when reading and on near objects. The hope is to correct their vision either with auto-focusing lenses that sit on top of the eyes or perhaps even inside of them.

The first prototype smart lenses could arrive "early next year," Novartis CEO Joseph Jimenez told Bloomberg, adding that Novartis could start marketing and monetizing the smart lenses in around five years. Of course, the lenses would only go to market after U.S. Food and Drug Administration approval. Google employees recently met with FDA officials who regulate medical devices related to eye health.

Related: Google Glass Creator Babak Parviz Snagged by Amazon

"The promise here is the holy grail of vision care, to be able to replicate the natural functioning of the eye," Jimenez said in the Bloomberg report. "Think about a contact lens that could help the eye autofocus on that newspaper and then when you look up it would autofocus in the distance."

There was no word from either company as to whether or not the lenses will include LED lights that could light up to alert wearers when their glucose levels cross above or below specific threshold levels. Google said it was investigating a possible LED-driven warning feature when it laid out its initial concept for the lenses.

And, we assume, and frankly hope, that the lenses won't be able to snap pictures in the blink of an eye.

Related: How Google Is Taking Over Our Lives

Kim Lachance Shandrow

Former West Coast Editor

Kim Lachance Shandrow is the former West Coast editor at Previously, she was a commerce columnist at Los Angeles CityBeat, a news producer at MSNBC and KNBC in Los Angeles and a frequent contributor to the Los Angeles Times. She has also written for Government Technology magazine, LA Yoga magazine, the Lowell Sun newspaper,, and the former U.S. Surgeon General, Dr. C. Everett Coop. Follow her on Twitter at @Lashandrow. You can also follow her on Facebook here

Related Topics

Editor's Pick

Everyone Wants to Get Close to Their Favorite Artist. Here's the Technology Making It a Reality — But Better.
The Highest-Paid, Highest-Profile People in Every Field Know This Communication Strategy
After Early Rejection From Publishers, This Author Self-Published Her Book and Sold More Than 500,000 Copies. Here's How She Did It.
Having Trouble Speaking Up in Meetings? Try This Strategy.
He Names Brands for Amazon, Meta and Forever 21, and Says This Is the Big Blank Space in the Naming Game
Thought Leaders

The Collapse of Credit Suisse: A Cautionary Tale of Resistance to Hybrid Work

This cautionary tale serves as a reminder for business leaders to adapt to the changing world of work and prioritize their workforce's needs and preferences.

Business News

Meta Employees Interrogate Mark Zuckerberg in Town Hall Meeting

The CEO fielded tough questions from rattled staffers at an all-hands meeting.

Business News

These Are the Most and Least Affordable Places to Retire in The U.S.

The Northeast and West Coast are the least affordable, while areas in the Mountain State region tend to be ideal for retirees on a budget.

Business News

American Airlines Sued After Teen Dies of Heart Attack Onboard Flight to Miami

Kevin Greenridge was traveling from Honduras to Miami on June 4, 2022, on AA Flight 614 when he went into cardiac arrest and became unconscious mid-flight.

Business News

TikTok Influencer Reveals She Makes $350,000 a Month on OnlyFans. 'Absolutely Unreal.'

When Tara Lynn promoted her OnlyFans page on TikTok, she saw her income more than double.